The price of Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) closed at $0.99 in the last session, down -10.86% from day before closing price of $1.11. In other words, the price has decreased by -$0.1205 from its previous closing price. On the day, 551266 shares were traded. SONN stock price reached its highest trading level at $1.1200 during the session, while it also had its lowest trading level at $0.9805.
We take a closer look at SONN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.14 while its Price-to-Book (P/B) ratio in mrq is 5.50.
Stock Price History:
Over the past 52 weeks, SONN has reached a high of $9.37, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 1.5270, while the 200-Day Moving Average is calculated to be 3.4639.
According to the various share statistics, SONN traded on average about 4.31M shares per day over the past 3-months and 412.87k shares per day over the past 10 days. A total of 7.35M shares are outstanding, with a floating share count of 7.23M. Insiders hold about 1.72% of the company’s shares, while institutions hold 3.50% stake in the company. Shares short for SONN as of Oct 13, 2022 were 169.84k with a Short Ratio of 0.14M, compared to 42.72k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.92% and a Short% of Float of 4.05%.
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.51 for the current quarter, with a high estimate of -$1.51 and a low estimate of -$1.51, while EPS last year was -$2.45. The consensus estimate for the next quarter is -$1.15, with high estimates of -$1.15 and low estimates of -$1.15.
Analysts are recommending an EPS of between -$6.68 and -$6.68 for the fiscal current year, implying an average EPS of -$6.68. EPS for the following year is -$4.91, with 1 analysts recommending between -$4.91 and -$4.91.
A total of 1 analysts have provided revenue estimates for SONN’s current fiscal year. The highest revenue estimate was $400k, while the lowest revenue estimate was $400k, resulting in an average revenue estimate of $400k. In the same quarter a year ago, actual revenue was $484k, down -17.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $100k in the next fiscal year. The high estimate is $100k and the low estimate is $100k. The average revenue growth estimate for next year is down -75.00% from the average revenue estimate for this year.